Dr. Reddys Quarterly Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Dr. Reddys Quarterly Results    (REDY)

Here are the latest quarterly results of Dr. Reddys. For more details, see the Dr. Reddys financial fact sheet and Dr. Reddys share price and chart. For a sector overview, read our pharmaceuticals sector report.

Excel Export | Annual Financial Info | Result Scoreboard

Dr. Reddys Quarterly Results

No. of Mths
Qtr. Ending
3
Sep-18
*
3
Dec-18
*
3
Mar-19
*
3
Jun-19
*
3
Sep-19
*
3
Dec-19
*
3
Mar-20
*
3
Jun-20
*
8-Qtr Chart
Click to enlarge
Net Sales Rs m38,17538,64640,29638,58248,12843,97144,48944,265 
Other income Rs m1,2821,0238334,301540673736871 
Turnover Rs m39,45739,66941,12942,88348,66844,64445,22545,136 
Expenses Rs m30,58230,60032,10731,16537,49046,85834,99733,052 
Gross profit Rs m7,5938,0468,1897,41710,638-2,8879,49211,213 
Depreciation Rs m2,7862,9032,8722,8903,1312,8692,7412,923 
Interest Rs m208241245298303152230233 
Profit before tax Rs m5,8815,9255,9058,5307,744-5,2357,2578,928 
Tax Rs m8071,0111,5081,928-3,207325-4493,059 
Profit after tax Rs m5,0744,9144,3976,60210,951-5,5607,7065,869 
Gross profit margin %19.920.820.319.222.1-6.621.325.3 
Effective tax rate %13.717.125.522.6-41.4-6.2-6.234.3 
Net profit margin %13.312.710.917.122.8-12.617.313.3 
Diluted EPS Rs 30.6 29.7 26.5 39.8 66.1 -33.6 46.5 35.4  
Diluted EPS (TTM) Rs 93.5 105.4 115.5 126.6 162.1 98.9 118.9 114.5  
 Subscriber Feature                  
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Read: Dr. Reddys 3QFY19 Result Performance Review

More Pharmaceuticals Company Quarterly Results:   ALEMBIC LTD  WOCKHARDT  ALKEM LABORATORIES  INDOCO REMEDIES  DIVIS LABORATORIES  

Compare DR. REDDYS LAB With:   ALEMBIC LTD  WOCKHARDT  ALKEM LABORATORIES  INDOCO REMEDIES  DIVIS LABORATORIES  

Compare DR. REDDYS LAB With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices End Flat; Metal and Telecom Stocks Witness Buying(Closing)

Indian share markets continued to trade on a volatile note and ended on a flat note today. At the closing bell, the BSE Sensex stood lower by 24 points (down 0.1%).

Views on news

DR. REDDYS LAB Announces Quarterly Results (3QFY19); Net Profit Up 67.0% (Quarterly Result Update)

Feb 4, 2019 | Updated on Feb 4, 2019

For the quarter ended December 2018, DR. REDDYS LAB has posted a net profit of Rs 5 bn (up 67.0% YoY). Sales on the other hand came in at Rs 39 bn (up 0.8% YoY). Read on for a complete analysis of DR. REDDYS LAB's quarterly results.

More Views on News

Most Popular

These 5 Smallcaps Deserve a Place in Your Coffee Can Portfolio (Profit Hunter)

Jul 28, 2020

When it comes to quality stocks, doing less is more.

My Best Trading Ideas When Interest Rates Are So Low (Fast Profits Daily)

Jul 23, 2020

India's interest rates are lower than the inflation rate. Here are the best trades for this situation.

Before You Buy Your First Electric Vehicle Consider Buying this Stock (Profit Hunter)

Jul 29, 2020

As competition intensifies in the electric vehicle space, only few will create huge wealth over the years.

Gold or Silver: Which One Should You Buy Now? (Fast Profits Daily)

Jul 24, 2020

Silver and gold are both vying for your attention. Which is the better trade today?

More

Covid-19 Proof
Multibagger Stocks

Covid19 Proof Multibaggers
Get this special report, authored by Equitymaster's top analysts now!
We will never sell or rent your email id.
Please read our Terms

DR. REDDYS LAB SHARE PRICE


Aug 5, 2020 (Close)

TRACK DR. REDDYS LAB

  • Track your investment in DR. REDDYS LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

DR. REDDYS LAB - TEVA PHARMA COMPARISON

COMPARE DR. REDDYS LAB WITH

MARKET STATS